Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma.
Wen-Long YuGuanzhen YuHui DongKe ChenJun XieHua YuYuan JiGuang-Shun YangAi-Jun LiWen-Ming CongGuang-Zhi JinPublished in: Journal of gastroenterology (2020)
Current prognostic models were accurate in predicting recurrence for ICC patients after surgical resection.